Why There Is No Fixed Number
PRP uses your own platelets, so there is no cumulative dose limit in the way there is with some medications. The constraint is not safety in that sense — it is whether further treatment is likely to add anything.
The pooled trial data is the useful guide here. Across seven randomized trials covering 660 patients, there was no significant difference from control at 4 weeks, with benefit appearing at 12 weeks and sustained at 24. Treatment builds over months.
That timeline argues against frequent repeat sessions. Re-treating at six or eight weeks means intervening before the first treatment has demonstrated what it will do.
A reasonable approach
Treat, then reassess at around 12 to 24 weeks using how you are actually doing rather than a calendar.
If there has been meaningful improvement, maintenance can be considered when it declines. If there has been none by 24 weeks, further sessions of the same treatment are unlikely to change that, and the more useful conversation is about why.
When More Is Not Better
If two properly spaced treatments have produced no measurable change, the honest conclusion is usually that PRP is not addressing your underlying cause — not that you need a third.
Common reasons PRP does not help:
- Advanced vascular disease — a circulation problem that needs medical management
- Poorly controlled diabetes — affecting both vessels and nerves
- Medication effects — several common drug classes cause ED, and no injection overcomes an ongoing pharmacological effect
- Low testosterone — a treatable cause that PRP does not address
- Psychological factors — which respond to a different kind of help
Each of those has its own treatment, and identifying it is more valuable than another session. This is why the erectile dysfunction evaluation matters more than the injection.
Safety of Repeat Treatment
Across the published studies, side effects were described as mild and transient with no major adverse events, and repeat treatment did not raise particular safety concerns. The material is autologous, so allergy and rejection are not issues.
The practical limits are the blood draw itself — not appropriate with significant anaemia — and platelet disorders, active infection, or anticoagulation that cannot be paused.
What We Do
We do not sell packages of sessions upfront. We treat, reassess at an interval that lets the treatment demonstrate what it does, and recommend more only if the response justifies it. If it does not, we will say so rather than continue selling.
See how long a P-Shot lasts and whether it is worth it.
